Press ReleasesArchived Press ReleasesFor information regarding press releases please contact us at:
Phone: (402) 452-5437
Fax: (402) 452-5461
E-mail: investorrelations@transgenomic.com DisclaimerThe following historical press releases contain statements that reflected management's views and estimates of future economic circumstances, industry conditions, company performance and financial results applicable on the dates they were first issued. Investors should not assume that statements made in these documents remain accurate and complete as of any later date. Such statements were and remain subject to certain factors, risks and uncertainties, including those described in Transgenomic, Inc.'s reports to the Securities and Exchange Commission. Any change in such factors, risks and uncertainties could have caused the actual results, events and performance to differ materially from those referred to in such statements. Transgenomic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any of these documents to reflect any change in Transgenomic's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements were based. Available Archives2003 Archive| December 9, 2003 | View | Transgenomic Establishes Revolving Credit Facility With Laurus Funds | | | | December 4, 2003 | View | Transgenomic’s WAVE System Advances Study of Genetic Variation Implicated in Leukemia | | | | December 2, 2003 | View | Transgenomic Announces Discovery Services Agreement with Novartis Pharmaceuticals Corp. | | | | November 20, 2003 | View | Transgenomic’s Optimase Polymerase Now Distributed by Fisher Scientific | | | | November 18, 2003 | View | TBIO Selected by Intercell AG to Develop Manufacturing Process for Immune Stimulating Oligonucleotide | | | | November 11, 2003 | View | Transgenomic Inc. Reports Third Quarter 2003 Results | | | | November 11, 2003 | View | Webcast Alert: Transgenomic Announces 3rd Quarter 2003 Earnings Release Conference Call Webcast | | | | November 4, 2003 | View | Webcast Alert: Transgenomic Announces 3Q 2003 Earnings Release Conference Call Webcast | | | | October 16, 2003 | View | Transgenomic WAVE ® System Enables Analysis of Polymicrobial Infections Observed in Transplant Patients | | | | September 25, 2003 | View | Transgenomic to Provide Additional Specialty Nucleic Acid Products to Geron Corporation | | | | September 10, 2003 | View | Transgenomic Announces Launch of SURVEYOR™ Product Line | | | | September 4, 2003 | View | Benefits of Transgenomic’s WAVE® System Reviewed at Colorectal Cancer Meeting | | | | August 28, 2003 | View | Transgenomic Announces $4.5 Million Private Placement | | | | August 5, 2003 | View | TBIO Reports Second Quarter and Year-to-Date 2003 Results | | | | August 5, 2003 | View | Webcast Alert: Transgenomic Inc. Announces Second Quarter 2003 Earnings Release Webcast | | | | July 15, 2003 | View | TBIO Updates Second Quarter 2003 | | | | June 4, 2003 | View | TBIO and Geron Sign Licensing Agreement Covering Novel Class of Synthetic Nucleic Acids | | | | May 30, 2003 | View | TBIO Introduces High Sensitivity Mutation Scanning Technology | | | | May 29, 2003 | View | TBIO Announces Changes in Management Responsibilities in Line With Evolving Business Segment Focus | | | | May 5, 2003 | View | Transgenomic Inc. Reports First Quarter 2003 Results | | | | May 5, 2003 | View | Webcast Alert: TBIO Announces First Quarter 2003 Results Conference Call Webcast | | | | April 29, 2003 | View | Webcast Alert: TBIO Announces Fourth Quarter 2003 Conference Call Webcast | | | | February 4, 2003 | View | Transgenomic Inc. Reports Fourth Quarter and Fiscal Year 2002 Results | | | | February 4, 2003 | View | Webcast Alert: TBIO Announces Fourth Quarter 2002 Earnings Release Conference Call Webcast | | | | January 28, 2003 | View | Webcast Alert: TBIO Announces Fourth Quarter 2002 Earnings Release Conference Call Webcast | | | | January 3, 2003 | View | Transgenomic Announces Expense Reductions | | |
|